1,2 Pharmaceutical companies aim to stimulate patients' requests for brand-name medications and increase the likelihood physicians will honor such requests. 3, 4 Presently, little is known about how frequently physicians comply with such a request or the factors predicting this behavior.
Methods. The data come from a national survey of 3500 randomly sampled physicians in 7 specialties. Additional information on the sampling, survey administration, and analyses for this study are described at length in several other published articles. [5] [6] [7] Of the 3500 physicians in the original sample, 2938 were eligible for the survey (others were ineligible because they were on leave, not actively practicing, practicing in a nonsampled specialty, out of the country, or deceased). Of the remaining eligible physicians, 1891 participated in the survey, representing a 64% overall response rate.
Results.
The results of the multivariable analyses of prescribing behavior as a function of physician characteristics are given in the Table. The multivariable regression shows that 43% of physicians in practice more than 30 years sometimes or often give in to patients' demands for brand-name drugs compared with 31% physicians in practice for 10 years or less (P=.001). Among the various specialties, pediatricians, anesthesiologists, cardiologists, and general surgeons were significantly less likely to acquiesce to patient demands relative to internal medicine physicians (P Ͻ.001). Physicians working primarily in solo or 2-person practices were significantly more likely to acquiesce to patient demands than those working in a hospital or medical school setting (46% vs 35%; P=.04).
Two specific forms of industry relationships were associated with significant differences in the percentage of physicians who acquiesced to patient demands. More than a third who received free food and/or beverages in the workplace honored patient requests sometimes or often compared with those who had not received food and beverages (39% vs 33%; P = .003). Similar significant differences were found among those receiving drug samples (40% vs 31%; P = .005). Also, physicians who sometimes or often met with industry representatives to stay up to date were significantly more likely to comply with patients' demands than those who did not (40% vs 34%; P = .007).
See also pages 179 and 229 and Editor's Note at end of article
Comment. Approximately 4 of 10 physicians report that they sometimes or often prescribe a brand-name drug to a patient when a generic is available because the patient wanted it. These numbers suggest that the unnecessary costs associated with this practice to the health care system could be substantial.
We found that certain physician-industry relationships were significantly, positively associated with accommodating patient requests for brand names. Physicians who received industry-provided food and/or beverages in the workplace and samples were significantly more likely to accede to patient demands for brand-name drugs. Also, physicians who meet with industry representatives to stay up to date are more like to give in to patient requests for brand names. These findings are likely the result of the fact that industry gifting of food and beverages coincides with "up-to-date meetings" with drug representatives; thus, these factors work together to increase the likelihood that physicians will prescribe a brand name and clearly serve a marketing function.
Potential interventions that could dramatically reduce this practice include having a closed health system (such as the Veterans Health Administration or Britain) that gives the pharmacy primary control over these decisions, with override capability for rare situations when it is necessary (eg, allergy to generic additive, idiosyncratic responses). Also, hospitals and health systems could consider policies that prevent individual physicians from receiving samples and instead require samples be given to a pharmacy or other appropriate office in a hospital or health system. Finally, payers such as Medicare or commercial insurers who are inter- Abbreviation: HMO, health maintenance organization. a Model: Pr(sometimes or often prescribed brand when patient requested it even when generic was available) = ⌳[␣ ϩ ␤ 1 (male) ϩ ␤ 2 (attended medical school in the United States or Canada) ϩ ␤ 3 (family practice specialty) ϩ ␤ 4 (pediatrics specialty) ϩ ␤ 5 (anesthesiology specialty) ϩ ␤ 6 (psychiatry specialty) ϩ ␤ 7 (general surgery specialty) ϩ ␤ 8 (cardiology specialty) ϩ ␤ 9 (solo or 2-person practice) ϩ ␤ 10 (group practice) ϩ ␤ 11 (HMO or other practice) ϩ ␤ 12 (multiple practice settings) ϩ ␤ 13 (received industry-provided food or beverages in workplace) ϩ ␤ 14 (received free drug samples) ϩ ␤ 15 (received gift or travel subsidies) ϩ ␤ 16 (received payments for speaking or consulting) ϩ ␤ 17 (sometimes or often met with industry representatives to stay up to date) ϩ ␤ 18 (sometimes or often read medical journals to stay up to date) ϩ ␤ 19 (sometimes or often read newspapers or magazines, listened to the radio, or watched television to stay up to date) ϩ ␤ 20 (sometimes or often attended lectures or rounds at health care facility to stay up to date)], where ⌳ is the cumulative distribution function of the logistic distribution. Standard errors were clustered on physician specialty. Pr indicates probability.
b The actual survey item read "In the last year how often have you prescribed a brand-name drug when an equivalent generic was available because the patient asked for the brand-name drug specifically?" The response categories were "never," "rarely," "sometimes," and "often." For analysis, we grouped "sometimes" and "often" (coding them as 1) and "never" and "rarely" (coding them as 0) responses.
c Sample size for regression, n = 1806.
ested in increasing the use of generic drugs may consider banning physicians from accepting food and beverages in the workplace. Any potential interventions should be targeted toward older physicians, internists, and those in solo or 2-person practices. Our study has several limitations. First, because of social desirability bias, our results likely represent a lowerbound estimate of the actual frequency of physicians prescribing brand-name drugs at the patients' requests. Second, we were unable to adjust the result for the frequency with which physicians were asked by patients for a specific brand-name drug. Finally, our study was not able to examine whether a brand-name drug was actually dispensed at the pharmacy, given that some states have laws that allow pharmacists to substitute a generic for a brand-name prescription.
